Page 17 - Best oncologists: TOP 664 doctors

Pioneered diagnostic criteria for paraneoplastic neurological syndromes – Dr. Graus is a leading figure in neuro-oncology at Hospital Quiron Barcelona.

• Founder and past president of the European Association of Neuro-Oncology
• Specializes in gliomas, brain lymphomas, and treatment-related neurotoxicities
• Trained in neuro-oncology at Memorial Sloan-Kettering Cancer Center
• Former Chief of Neurology at Hospital Clinic Barcelona
• Honored with Doctor Honoris Causa by Lyon University

15,000+ surgical procedures performed – Dr. de Lacy is a pioneer in minimally invasive techniques for colon and rectal cancer at Hospital Quiron Barcelona.

• Performs 1,000+ interventions annually using laparoscopic and robotic methods
• World-renowned pioneer in gastrointestinal surgery techniques
• President of the Association of Surgeons-Endoscopists in Europe
• Founder of TaTME technique for rectal cancer surgery

Specializes in precision radiotherapy at Assuta Medical Center – a leading oncology facility in Israel.

• Focuses on targeted radiation therapy for multiple cancer types
• Uses advanced imaging for accurate tumor targeting
• Part of a multidisciplinary oncology team at Assuta
• Works with cutting-edge radiotherapy technologies

Prof. Jong Kyun Lee specializes in pancreatic and bile duct cancers – recognized as one of Asia's top gastroenterologists at Samsung Medical Center.

• Trained at Seoul National University and the University of California
• Expert in managing complex pancreatic and gallbladder conditions
• Member of the Korean Pancreatobiliary Association
• Affiliated with the Korean Society of Gastrointestinal Endoscopy

Professor Kyu Taek Lee specializes in pancreatic, bile duct, and gallbladder cancers at Samsung Medical Center – one of South Korea's top hospitals.

• Trained at Stanford University School of Medicine and Kyoto Second Red Cross Hospital
• of gastroenterology experience
• Member of The Korean Society of Gastrointestinal Endoscopy
• Focuses on complex GI cancer cases

Specializes in breast, colorectal, and throat cancer treatments at Samsung Medical Center – a leading healthcare institution in South Korea.

• Focuses on personalized radiation therapy plans
• Experienced in treating colorectal cancer with radiation
• Provides specialized care for throat cancer patients

Specializes in gynecologic oncology at Samsung Medical Center – one of South Korea's leading cancer centers.

• Focuses on ovarian and cervical cancer treatments
• Expert in minimally invasive surgical techniques
• Dedicated to personalized treatment plans
• Provides comprehensive care for female reproductive cancers

Prof. Hyun Moo Lee is a leading general surgeon with of experience in pediatric surgery and GI tract disorders at Samsung Medical Center.

• Specializes in liver, gallbladder, bile duct, and pancreas diseases
• Member of multiple prestigious surgical societies including the International Hepato-Pancreato-Biliary Association
• Recipient of multiple awards from the Korean Association of HBP Surgery
• Published research on tumor locations in gallbladder cancer

Specializes in breast cancer and precision radiotherapy at Samsung Medical Center, a top-tier cancer care facility.

• Focuses on personalized treatment plans for optimal outcomes
• Experienced in mastectomy and breast-conserving surgeries
• Dedicated to delivering precise radiation therapy
• Board-certified oncologist with extensive experience

Specializes in gynecologic oncology at Samsung Medical Center, a leading institution in cancer care.

• Expert in Da Vinci Robotic System procedures
• Focuses on cervical and breast cancer treatments
• Provides personalized chemotherapy plans
• Skilled in precision hysterectomy and trachelectomy

Head of Urology at Samsung Medical Center – Dr. Choi leads one of Korea's top urology teams with a focus on precision cancer surgery.

• Specializes in robotic-assisted prostatectomies and complex urologic oncology
• of experience in urological cancer treatments
• Leads a dedicated team for prostate, bladder, and kidney cancers
• Works at a JCI-accredited medical center with advanced technology

Professor Mordechai Vias specializes in endocrinology at Assaf Harofeh Medical Center.

• Expert in hormonal aspects of colon cancer
• Professor with extensive academic background
• Works at a leading medical center in Israel

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.